GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2308.35 -71.50 (-3.00%) | NSE 2313.40 -66.80 (-2.81%) | Trade | Add

BSE Live

Jan 23, 16:01

2308.35 -71.50 (-3.00%)

Volume

AVERAGE VOLUME

5-Day

3,293

10-Day

2,791

30-Day

5,804

3,136

Prev. Close

2379.85
Open Price

2390.85

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 23, 15:58

2313.40 -66.80 (-2.81%)

Volume

AVERAGE VOLUME

5-Day

74,405

10-Day

65,656

30-Day

82,586

86,873

Prev. Close

2380.20
Open Price

2381.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2313.40 (10)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 15	Dec 13	Dec 12	Dec 11	Dec 10
Per Share Ratios
Basic EPS (Rs.)	55.68	59.25	68.15	50.84	66.55
Diluted EPS (Rs.)	55.68	59.25	68.15	50.84	66.55
Cash EPS (Rs.)	58.68	61.60	70.26	53.25	68.63
Book Value [ExclRevalReserve]/Share (Rs.)	218.61	238.15	237.30	226.67	227.95
Book Value [InclRevalReserve]/Share (Rs.)	218.61	238.15	237.30	226.67	227.95
Dividend / Share(Rs.)	62.50	50.00	50.00	45.00	40.00
Revenue from Operations/Share (Rs.)	388.13	300.60	310.53	280.50	250.90
PBDIT/Share (Rs.)	97.50	85.36	119.55	111.21	103.61
PBIT/Share (Rs.)	94.51	83.02	117.44	108.80	101.53
PBT/Share (Rs.)	88.38	86.10	99.94	70.72	101.45
Net Profit/Share (Rs.)	55.68	59.25	68.15	50.84	66.55
Profitability Ratios
PBDIT Margin (%)	25.12	28.39	38.49	39.64	41.29
PBIT Margin (%)	24.34	27.61	37.81	38.78	40.46
PBT Margin (%)	22.77	28.64	32.18	25.21	40.43
Net Profit Margin (%)	14.34	19.71	21.94	18.12	26.52
Return on Networth / Equity (%)	25.47	24.88	28.71	22.42	29.19
Return on Capital Employed (%)	37.57	22.14	25.61	19.99	28.98
Return on Assets (%)	14.57	15.93	18.68	14.30	20.19
Total Debt/Equity (X)	0.00	0.00	0.00	0.00	0.00
Asset Turnover Ratio (%)	101.58	80.83	85.13	78.90	76.13
Liquidity Ratios
Current Ratio (X)	2.32	2.95	3.13	2.99	2.89
Quick Ratio (X)	1.99	2.56	2.79	2.61	2.56
Inventory Turnover Ratio (X)	8.91	7.44	9.33	7.20	7.55
Dividend Payout Ratio (NP) (%)	112.24	84.38	73.36	88.51	60.10
Dividend Payout Ratio (CP) (%)	106.51	81.16	71.16	84.51	58.28
Earnings Retention Ratio (%)	-12.24	15.62	26.64	11.49	39.90
Cash Earnings Retention Ratio (%)	-6.51	18.84	28.84	15.49	41.72
Valuation Ratios
Enterprise Value (Cr.)	26,926.07	23,324.69	16,309.49	14,423.24	17,899.61
EV/Net Operating Revenue (X)	8.19	9.16	6.20	6.07	8.42
EV/EBITDA (X)	32.60	32.26	16.11	15.31	20.40
MarketCap/Net Operating Revenue (X)	8.77	9.96	6.97	6.90	9.34
Retention Ratios (%)	-12.24	15.61	26.63	11.48	39.89
Price/BV (X)	15.57	12.57	9.13	8.54	10.28
Price/Net Operating Revenue	8.77	9.96	6.97	6.90	9.34
Earnings Yield	0.02	0.02	0.03	0.03	0.03